Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,441 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Measurement Clear all

Conditions: Trauma Injury
Interventions: Immunofluorescence Imaging, DCE-MRI; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: Irvine, California • Baltimore, Maryland • Boston, Massachusetts + 1 more

Conditions: Opioid Abuse and Addiction
Interventions: MBC4OUD; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Disease of Cardiovascular System
Interventions: Symptoms of chronic illness.; Other
Lead sponsor: Aventyn, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Timeline: 2018
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin
Interventions: Onglyza (saxagliptin), Diabex, 5-mg saxagliptin/1000 mg metformin, 5-mg saxagliptin/500 mg metformin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Deep Venous Thrombosis
Interventions: Not listed
Lead sponsor: Diagnostica Stago; Industry
Eligibility: Up to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Sepsis
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Rochester, Minnesota

Conditions: Intra-Abdominal Hypertension
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 2 Months
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Healthy, Unconscious
Interventions: Alonefire SV003 10W 365nm UV Flashlight; Device
Lead sponsor: Indiana University; Other
Eligibility: 1 Day to 75 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Pregnancy - Labor Monitoring
Interventions: Not listed
Lead sponsor: Reproductive Research Technologies, LP; Industry
Eligibility: 15 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 3
States / cities: Phoenix, Arizona • Philadelphia, Pennsylvania • Galveston, Texas

Conditions: Parkinson Disease
Interventions: Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature, Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 11
States / cities: Tucson, Arizona • Sacramento, California • Miami, Florida + 8 more

Conditions: Hemostasis Monitoring
Interventions: PCM and ROTEM; Device
Lead sponsor: Entegrion, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: St Louis, Missouri • Columbus, Ohio • Philadelphia, Pennsylvania

Conditions: HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7
Interventions: Computed Tomography, F-18 16 Alpha-Fluoroestradiol, Laboratory Biomarker Analysis, Positron Emission Tomography; Procedure · Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 25
States / cities: Birmingham, Alabama • Duarte, California • Los Angeles, California + 16 more

Conditions: Atopic Dermatitis, Psoriasis
Interventions: Vitamin D3, Placebo; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: San Diego, California • Denver, Colorado • Portland, Oregon

Conditions: Fever
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Computer Controlled Telephone Counseling, Physician information and management recommendations; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pre-Eclampsia
Interventions: Echocardiogrpahy and non-invasive monitoring; Diagnostic Test
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Oral Hormonal Contraceptive Use, Neural Activity, Mood, Hedonic Function
Interventions: Levonorgestrel/ethinyl estradiol, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Postpartum Hemorrhage, Postsurgical Bleeding, Abdominal Ultrasound, FAST Scan, Non-invasive Hemoglobin Measurement
Interventions: FAST scan and non-invasive hemoglobin measurement; Device
Lead sponsor: Northwestern University; Other
Eligibility: 12 Years to 60 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Substance Use Disorders, Opioid Use Disorder
Interventions: Patient Reported Outcome Measure; Other
Lead sponsor: Brandeis University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Fall River, Massachusetts

Conditions: Measurement of Refractive Error
Interventions: Refractive Error; Diagnostic Test
Lead sponsor: Johnson & Johnson Surgical Vision, Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Solitary Pulmonary Nodule, Multiple Pulmonary Nodules
Interventions: Not listed
Lead sponsor: Fresh Medical Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 15
States / cities: Los Angeles, California • San Diego, California • Stanford, California + 12 more

Conditions: Congestive Heart Failure
Interventions: Ultrafiltration, Ultrafiltration using BVM; Other
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Cystic Fibrosis-related Diabetes
Interventions: Measurement of differentially methylated insulin DNA; Diagnostic Test
Lead sponsor: University of Nebraska; Other
Eligibility: Up to 21 Years
Enrollment: 40 participants
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: No Intervention, Observational Study; Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: 6 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

ICG Fluorescence Imaging in Post-traumatic Infection

Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution

Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements

Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis

A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status

Intra-Abdominal Hypertension in Neonatal Intensive Care Patients

External Nitric Oxide Measurement Through SNO Degradation

Comparison of SureCALL® EMG Labor Monitor® and Tocodynamometer to Intrauterine Pressure Catheter Measurement (IUPC) Measurement in Pregnant Women

Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation

Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever

Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Contraceptive Hormone and Reward Measurement (CHARM Study)

Abdominal Ultrasound Assessment in the Post-cesarean Patient

Piloting a Patient-Reported Outcome Measure for Opioid Use Disorder Recovery in a Clinical Setting

Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer

A Multi-Center Trial of the ProLung Test™

Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients

Measurement of Beta Cell Death in Individuals With Cystic Fibrosis

Physiologic Measure of VIPN